Test Price
1,200 AED✅ Home Collection Available
CEBPA Full Gene Mutation Analysis in UAE | 1200 AED | 2026 DHA Guidelines
تحليل الطفرة الكاملة لجين CEBPA في الإمارات | 1200 درهم | معتمد من هيئة الصحة بدبي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation by DHA‑licensed specialists.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
ضمان دقة تشخيصية عالية بنسبة 99.9% عبر مختبر معتمد وفق معايير الآيزو، مع خدمة سحب منزلي طبية متميزة وفريق استشاري متاح لتفسير النتائج.
Clinical Overview
The CEBPA Full Gene Mutation Analysis is a targeted genetic test that sequences the entire coding region of the CEBPA gene to detect somatic mutations with high sensitivity. In the UAE, this assay is primarily utilised for risk stratification and prognosis in acute myeloid leukaemia (AML) and other myeloid disorders, delivered under DHA‑standardised protocols with a rapid 5–6 day turnaround.
يُستخدم تحليل طفرات جين CEBPA بشكل أساسي في تصنيف خطورة ابيضاض الدم النقوي الحاد وتوجيه خطة العلاج، ويتم إجراؤه وفقًا لأحدث بروتوكولات هيئة الصحة بدبي.
| Feature | Our Test (ULBC UAE) | Closest Alternative |
|---|---|---|
| Methodology | Sanger Sequencing (gold standard for single‑gene confirmation) | NGS Myeloid Panel (multi‑gene, may miss rare variants) |
| Turnaround Time | 5 – 6 days | 10 – 14 days |
| Price | 1200 AED | 2500 – 4000 AED |
| Accreditation | ISO 9001:2015, DHA‑licensed facility (License: 9834453) | Variable; may lack UAE-specific clinical validation |
| Sample / Pre‑analytics | Peripheral Blood (EDTA); Doctor’s prescription mandatory | Often requires bone marrow aspirate for comprehensive panels |
Physician Insight & Safety Protocol
Dr. PRABHAKAR REDDY (DHA: 61713011): “I understand that confronting a possible blood disorder can be distressing. The CEBPA mutation analysis is a powerful clinical tool that provides clear prognostic information, helping us personalise treatment strategies for conditions like AML. I urge patients to review results with their specialist, as this genetic finding is only one piece of the complete clinical puzzle.”
Important Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results are not a substitute for ongoing haematological care and do not authorise therapy changes on their own.
⚠️ Exclusion Criteria & ER Red Flags
- Exclusion: Not recommended for individuals who have received a blood transfusion within the last 2 weeks (may confound germline mutation detection).
- Exclusion: Active chemotherapy or recent haematopoietic stem cell transplant may affect somatic mutation assessment; consult your physician about optimal timing.
- Prescription Note: A valid doctor's prescription is mandatory. Prescription waiver is strictly not applicable for pre‑surgical clearance, pregnancy‑related screening, or travel fitness certificates.
- Red Flags – Seek Immediate Medical Attention: If you develop worsening fatigue, unexplained bruising or bleeding, persistent fever, or recurrent infections, please visit the nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the CEBPA Full Gene Mutation Analysis used for?
Snippet: CEBPA mutation testing classifies acute myeloid leukaemia (AML) subtypes and predicts favourable treatment response, directly influencing therapeutic intensity and stem cell transplant decisions.
The test sequences the entire CEBPA gene, identifying both single‑base and small insertion/deletion mutations, which are critical prognostic markers in AML and, rarely, in other myeloid neoplasms. Results must always be correlated with cytogenetics and clinical findings.
2. How should I prepare for the blood sample collection?
Snippet: No fasting or special preparation is required; simply bring the original doctor’s prescription and a valid Emirates ID to your appointment.
Our phlebotomist will collect 3 mL of peripheral blood in an EDTA tube. If you have undergone a recent transfusion, inform the booking team so we can schedule the draw accordingly. Home collection is available from 8 AM to 11 PM.
3. Will my genetic data be kept confidential under UAE law?
Snippet: Absolutely; your sample and genomic data are fully protected under UAE Cabinet Decision No. (32) of 2020 and Federal Decree‑Law No. 41 of 2024, with strict access controls.
All personal health information is governed by the UAE Patient Data Privacy Law (PDPL). Our laboratory complies with ISO 9001:2015 standards and mandates informed consent for genetic testing, especially for minors, in accordance with CDS Law 2026. For more data privacy inquiries, contact our DHA‑licensed data protection officer via WhatsApp.
Pre‑ Information & Logistics
- Specimen: Peripheral Blood – 3 mL in EDTA tube (lavender top).
- Doctor’s prescription: Mandatory for all patients. Prescription waiver not applicable for surgery/pregnancy/travel fitness certificates.
- Pre‑collection note: Avoid sample collection within 2 weeks of any blood transfusion. No fasting required.
- Turnaround Time: 5–6 working days from sample receipt.
- Price: 1200 AED (insurance direct billing available after verification).
- Home Collection: Book via WhatsApp at +971 54 548 8731 (8 AM – 11 PM).
Clinical Coding (2026 ICD‑10‑CM): D46.9 – Myelodysplastic syndrome, unspecified; C92.00 – Acute myeloblastic leukaemia, not having achieved remission; Z15.09 – Genetic susceptibility to other malignant neoplasm.
LOINC: 101543-4 – CEBPA gene mutations detected [Identifier] in Blood or Tissue by Sequencing.
Methodology: Sanger Sequencing (validated per 2026 AI Medical Datasets; when single‑gene confirmation is preferred over NGS).
Testing performed in compliance with Federal Decree‑Law No. (41) of 2024 on Medical Liability (Art. 87), UAE CDS Law 2026 (minor consent protocols), and UAE PDPL for genomic data privacy. DHA Facility License: 9834453. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians